Could a Three-Pronged attack keep High-Risk leukemia at bay?
Disease control
Terminated
This phase 1 trial is testing whether a combination of two drugs (venetoclax and azacitidine) followed by donor immune cell infusions can prevent relapse in people with very high-risk acute myeloid leukemia (AML) who have already received a stem cell transplant. The study enrolls…
Phase: PHASE1 • Sponsor: Antonio M Jimenez Jimenez • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC